Locate your nearest distributor

Location:
Type:
Text search:
Username:
Password:
Forgot password?

News Archive

Changes to Biohit Oyj’s management

10.08.2018 11:23

Lea Paloheimo, PhD (clinical biochemistry), born in 1951, was appointed as business development director at Biohit Oyj as of 6 August 2018. She continues being a member of Biohit Oyj's management team as in her previous role as Production & reasearch and Development Director at Biohit.   

Paloheimo has worked at Biohit since 2001. Before her career at Biohit, Paloheimo nworked as Chemist at Huslab, Salesmanager at Dasico A/S in Denmark, Researcher at Orion Diagnostica (Orion Corporation) and as a Chemist at the Clinical Chemistry department of United Laboratories Ltd. She carried out her PhD and postdoctoral research at the University of Copenhagen.

 

Additional information

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

 

Biohit Oyj in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission Innovating for health means that we provide innovative products and services to promote research and early diagnostics. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit's B series shares (BIOBV) are quoted on NASDAQ OMX Helsinki under small cap / Healthcare. www.biohithealthcare.com